Teleflex Incorporated
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow…
Medical - Instruments & Supplies
US, Wayne [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
Fundamentals
Valuation
| Metric | Q2 | Q3 | Δ in % | |
|---|---|---|---|---|
| EV/EBITDA | -2.92 | 58.59 | 60.35 | |
| Graham Fair Price | 17.83 | 71.60 | 60.77 | |
| PEG | 801.05 | 0.65 | 0.07 | |
| Price/Book | 17.90 | 2.58 | 2.19 | |
| Price/Cash Flow | -68.78 | 55.08 | 176.42 | |
| Prices/Earnings | -16.42 | 26.03 | 31.14 | |
| Price/Sales | 13.68 | 15.12 | 13.30 | |
| Price/FCF | -68.78 | 55.08 | 176.42 | |
| Naive Interpretation | member | |||
01 - Valuation ·
Weak
Fundamentals
Profitability
| Metric | Q2 | Q3 | Δ in % | |
|---|---|---|---|---|
| Gross Profit Margin | 0.97 | 0.56 | 0.56 | |
| Operating Margin | 16.10 | 0.20 | 0.17 | |
| ROA | 37.86 | 0.01 | 0.01 | |
| ROE | 0.02 | 0.02 | 41.07 | |
| ROIC | 0.02 | 0.02 | 23.03 | |
| Naive Interpretation | member | |||
02 - Profitability ·
Not Interpreted
Fundamentals
Financial Growth
| Metric | Q2 | Q3 | Δ in % | |
|---|---|---|---|---|
| Debt QOQ | 0.02 | -0.02 | -1.39 | |
| Dividends QOQ | < 0.005 | < 0.005 | -577.47 | |
| EBIT QOQ | -0.07 | 0.18 | 153.16 | |
| EPS QOQ | 4.31 | 0.40 | -90.72 | |
| FCF QOQ | -0.22 | 2.71 | 1127.06 | |
| Revenue QOQ | 0.02 | 0.02 | 22.04 | |
| Naive Interpretation | member | |||
03 - Financial Growth ·
Positive
Fundamentals
Leverage & Liquidity
| Metric | Q2 | Q3 | Δ in % | |
|---|---|---|---|---|
| Assets Turnover | n.A. | n.A. | n.A. | |
| Days Inventory Outstanding (DIO) | 172.74 | 172.33 | -0.24 | |
| Days Sales Outstanding (DSO) | 53.89 | 55.37 | 2.75 | |
| Inventory Turnover | 0.52 | 0.52 | 0.24 | |
| Debt/Capitalization | 0.27 | 0.28 | 2.95 | |
| Quick Ratio | 1.44 | 1.39 | -3.49 | |
| Naive Interpretation | member | |||
04 - Leverage & Liquidity ·
Weak
Fundamentals
Per Share Metrics
| Metric | Q2 | Q3 | Δ in % | |
|---|---|---|---|---|
| Book Value | 96.68 | 95.92 | -0.79 | |
| Cash | 5.41 | 5.21 | -3.73 | |
| Capex | 0.74 | 0.45 | -38.58 | |
| Free Cash Flow | 1.20 | 4.49 | 274.63 | |
| Revenue | 15.90 | 16.36 | 2.89 | |
| Naive Interpretation | member | |||
05 - Per Share Metrics ·
Positive
Fundamentals
Financial Health
06 - Financial Health ·
Bad